HCPLive
2014 Joint Meeting of the International Society of Endocrinology and the Endocrine Society

2014 Joint Meeting of the International Society of Endocrinology and the Endocrine Society | ICE/ENDO 2014

The joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014) is the world's largest endocrinology meeting and will feature a cutting-edge scientific program highlighting the latest advances in hormone research and clinical endocrinology.

Conference Coverages

Cooler Indoor Temps May Help 'Good Fat' Grow
Cooler Indoor Temps May Help 'Good Fat' Grow
Cooler indoor temperatures may stimulate the growth of healthy brown fat, while warm temperatures could cause the loss of this beneficial type of fat, according to a study published online June 22 in the journal Diabetes to coincide with presentation at the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
Osteoporosis Medication Shows Benefits in Increasing Bone Density
Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.
'Smart Capsule' Shows Potential in Weight Loss
A new pill could be the next tool in a patient’s fight to lose weight, according to a recent study.
Liraglutide Helps with Weight Loss and Delays Development of Type 2 Diabetes in Obese and Overweight Patients
Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.
Research Shows Benefits of Diabetes Drug in Heart Disease
A drug which has already been approved for patients with diabetes could have more benefits for people at risk of having heart disease, according a recent study.
Bone Loss Remains Concern For Gastric Bypass Patients Following Surgery
A recent study of patients who underwent bariatric surgery showed that even while their weight settled following their procedure their bone loss continued even two years after the operation.
Gut Microbiome-altering Drug Could Offer New Treatment for Diabetes
An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.

Most Popular

$vacMongoViewPlus$ $vAR$